MTLHY
Mitsubishi Chemical Group Corporation
OTC Markets OTCPKUSDEQUITY
Basic Materials
DELAYED
Last price
37.00
■ 0.00 (0.00%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
34.43
Prev close
37.00
Day high
34.43
Day low
34.43
Volume
2
Market cap
$10.05B
P/E (TTM)
—
52W range
26.51 – 38.74
Trailing performance
Returnvs SPY
1W
0.00%
+1.4%
1M
+2.07%
-1.7%
3M
+18.32%
+15.2%
6M
+10.41%
-0.7%
YTD
+25.85%
+13.6%
1Y
+36.28%
+16.3%
3Y
+25.17%
-49.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MTLHY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap$10.05B
Enterprise value$1.99T
Revenue (TTM)$3.83T
Gross profit$1.14T
EBITDA$364.26B
Net income$-41.95B
EPS (TTM)$-1.91
Free cash flow$424.45B
Total cash$544.02B
Total debt$1.85T
Book value / share$42.31
Shares outstanding271.74M
Float271.66M
Short % of float—
Dividend yield2.74%
Beta (5Y)0.69
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.87
EV / revenue0.52
EV / EBITDA5.47
Gross margin29.85%
Operating margin11.70%
Profit margin1.30%
Return on equity1.42%
Return on assets0.96%
Debt / equity73.78
Current ratio1.57
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $3.70T | $3.95T | $4.39T | $4.63T | — | -6.2% |
| Operating revenue | $3.70T | $3.95T | $4.39T | $4.63T | — | -6.2% |
| Cost of revenue | $2.63T | $2.91T | $3.24T | $3.40T | — | -9.5% |
| Gross profit | $1.07T | $1.04T | $1.15T | $1.24T | — | +3.1% |
| Selling, general & admin | $813.88B | $796.04B | $932.35B | $922.65B | — | +2.2% |
| Total operating expense | $1.04T | $905.60B | $893.08B | $1.07T | — | +14.7% |
| Operating income | $32.33B | $133.71B | $253.74B | $170.97B | — | -75.8% |
| Net interest income | -$29.37B | -$42.30B | -$21.28B | -$14.75B | — | +30.6% |
| Pre-tax income | $711.00M | $99.25B | $240.55B | $167.96B | — | -99.3% |
| Tax provision | $17.07B | $41.18B | $62.11B | $32.42B | — | -58.6% |
| Net income | $11.83B | $45.02B | $119.60B | $96.46B | — | -73.7% |
| Net income to common | $11.83B | $45.02B | $119.60B | $96.46B | — | -73.7% |
| Basic EPS | — | 158.20 | 420.35 | 339.25 | 623.40 | — |
| Diluted EPS | — | 158.15 | 403.85 | 324.95 | 575.15 | — |
| EBIT | $39.30B | $149.68B | $285.63B | $199.35B | — | -73.7% |
| EBITDA | $310.45B | $425.62B | $561.06B | $468.97B | — | -27.1% |
| Basic shares | — | 284.58M | 284.52M | 284.36M | 284.19M | — |
| Diluted shares | — | 284.67M | 296.14M | 297.38M | 308.03M | — |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $527.10B | $326.14B | $294.92B | $297.22B | +61.6% |
| Cash & short-term investments | $621.61B | $392.25B | $377.73B | $371.69B | +58.5% |
| Accounts receivable | $671.91B | $764.81B | $852.35B | $808.79B | -12.1% |
| Inventory | $669.13B | $759.42B | $799.25B | $797.88B | -11.9% |
| Total current assets | $2.10T | $2.06T | $2.19T | $2.15T | +1.6% |
| Property, plant & equipment | $2.10T | $2.00T | $2.04T | $1.91T | +4.6% |
| Goodwill & intangibles | $1.27T | $1.27T | $1.31T | $1.19T | -0.1% |
| Total assets | $5.88T | $5.89T | $6.10T | $5.77T | -0.3% |
| Total current liabilities | $1.40T | $1.50T | $1.72T | $1.66T | -6.6% |
| Current debt | $387.06B | $428.07B | $605.31B | $601.44B | -9.6% |
| Long-term debt | $1.50T | $1.61T | $1.60T | $1.64T | -6.8% |
| Total debt | $1.89T | $2.04T | $2.20T | $2.24T | -7.4% |
| Total liabilities | $3.46T | $3.61T | $3.83T | $3.79T | -4.1% |
| Retained earnings | $1.34T | $1.36T | $1.36T | $1.27T | -1.8% |
| Shareholder equity | $1.76T | $1.74T | $1.76T | $1.56T | +1.2% |
| Working capital | $694.35B | $561.40B | $466.72B | $485.79B | +23.7% |
| Net tangible assets | $492.99B | $470.93B | $449.52B | $377.83B | +4.7% |
| Shares issued | 1.44B | 1.51B | 1.51B | 1.51B | -4.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $135.04B | $150.69B | $240.55B | $167.96B | -10.4% |
| Depreciation & amortisation | $271.16B | $275.93B | $275.44B | $269.62B | -1.7% |
| Change in working capital | -$29.20B | $54.02B | $12.96B | -$35.16B | -154.1% |
| Operating cash flow | $436.29B | $552.85B | $465.15B | $355.19B | -21.1% |
| Capital expenditure | -$292.13B | -$324.97B | -$274.47B | -$281.00B | +10.1% |
| Investing cash flow | $124.47B | -$275.43B | -$246.09B | -$247.63B | +145.2% |
| Dividends paid | -$44.51B | -$45.53B | -$44.09B | -$42.65B | +2.3% |
| Financing cash flow | -$375.21B | -$246.65B | -$241.72B | -$60.78B | -52.1% |
| Free cash flow | $144.15B | $227.88B | $190.67B | $74.19B | -36.7% |
| End cash position | $527.10B | $326.14B | $294.92B | $297.22B | +61.6% |
| Line item | 2025-06-30 | YoY |
|---|---|---|
| Basic EPS | 69.80 | |
| Diluted EPS | 69.75 | |
| Basic shares | 281.19M | |
| Diluted shares | 281.39M |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $527.10B | $373.89B | $326.14B | +41.0% |
| Cash & short-term investments | $621.61B | $585.44B | $392.25B | +6.2% |
| Accounts receivable | $671.91B | $627.74B | $764.81B | +7.0% |
| Inventory | $669.13B | $663.02B | $759.42B | +0.9% |
| Total current assets | $2.10T | $2.02T | $2.06T | +3.8% |
| Property, plant & equipment | $2.10T | $2.03T | $2.00T | +3.1% |
| Goodwill & intangibles | $1.27T | $1.20T | $1.27T | +5.4% |
| Total assets | $5.88T | $5.66T | $5.89T | +3.8% |
| Total current liabilities | $1.40T | $1.26T | $1.50T | +11.4% |
| Current debt | $387.06B | $341.62B | $428.07B | +13.3% |
| Long-term debt | $1.50T | $1.54T | $1.61T | -2.7% |
| Total debt | $1.89T | $1.89T | $2.04T | +0.2% |
| Total liabilities | $3.46T | $3.28T | $3.61T | +5.7% |
| Retained earnings | $1.34T | $1.45T | $1.36T | -7.8% |
| Shareholder equity | $1.76T | $1.80T | $1.74T | -2.4% |
| Working capital | $694.35B | $760.81B | $561.40B | -8.7% |
| Net tangible assets | $492.99B | $600.93B | $470.93B | -18.0% |
| Shares issued | 1.44B | 1.51B | 1.51B | -4.3% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.04T | +13.5% |
| Next quarter | — | — | $1.03T | +9.4% |
| Current year | — | — | $3.97T | +6,798.2% |
| Next year | — | — | $4.01T | +0.8% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
37.00
0.00% from price
SMA 20
36.66
+0.92% from price
SMA 50
35.78
+3.42% from price
SMA 100
33.51
+10.43% from price
SMA 200
31.76
+16.50% from price
EMA 12
36.87
+0.36% from price
EMA 26
36.48
+1.44% from price
EMA 50
35.66
+3.76% from price
RSI (14)
81.2
Overbought
MACD (12,26,9)
0.39
Hist -0.04
ATR (14)
0.05
0.14% of price
Realised vol 30D
10.3%
Annualised
Bollinger upper
37.41
20, 2σ
Bollinger lower
35.92
20, 2σ
50 / 200 cross
Golden
35.78 vs 31.76
Trend bias
Above 200
+16.50%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.36
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
10.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-30.4%
Peak to trough
Max drawdown 5Y
-58.9%
Peak to trough
ATR 14
0.05
0.14% of price
Beta (reported)
0.69
5Y monthly, from filing
Dividends & splits
Forward rate$1.01 / yr
Forward yield2.74%
5-year avg yield3.73%
Payout ratio122.19%
Ex-dividend dateMar 31, 2026
Next pay date—
Last split—
Split date—
Headlines
Polyvinyl Alcohol Films Market Trends and Strategy Outlook 2026-2031 Featuring Kuraray, Aicello, Mitsubishi Chemical Group, Sekisui Chemical, Arrow Greentech and More
GlobeNewswire · 12d ago
[Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis)
GlobeNewswire · 31d ago
[Latest] Global Specialty Chemicals Market Size/Share Worth USD 1497 Billion by 2035 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire · 89d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.